Bristol-Myers Squibb buy fenjal
Start price
25.03.22
/
50%
€66.35
Target price
25.04.22
-
Performance (%)
6.07%
End price
26.04.22
€70.38
Summary
This prediction ended on 26.04.22 with a price of €70.38. The BUY prediction by fenjal finished with a performance of 6.07%. fenjal has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €0.49 are taken into consideration when calculating the performance. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bristol-Myers Squibb | -2.493% | -2.493% | -32.214% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to fenjal what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cons
Comments by fenjal for this prediction
In the thread Trading Bristol-Myers Squibb
Die von fenjal gewählte maximale Laufzeit wurde überschritten
Current prediction by fenjal for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.10
01.05.24
01.05.24
-
01.05.25
01.05.25
-0.55%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Stopped prediction by fenjal for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€68.08
03.01.23
03.01.23
-
03.01.24
03.01.24
-32.29%
28.12.23
28.12.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.48
19.06.20
19.06.20
€55.00
04.11.21
04.11.21
12.05%
04.04.21
04.04.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.54
18.04.19
18.04.19
€52.32
09.06.20
09.06.20
30.00%
09.06.20
09.06.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating